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Prevalence of overweight (OW) and obesity (O) in children and adolescents has been
increased in the past three decades. Increased arterial stiffness measuring by aortic
pulse wave velocity (PWVao) might be detected in OW/O children and adolescents.
The aim of our study was to compare the arterial function parameters (AFPs), such as
PWVao; aortic augmentation index (Aixao); aortic systolic blood pressure (SBPao) and
brachial systolic blood pressure (SBPbrach) measured simultaneously in O/OW patients
and healthy subjects. In our study 6,816 subjects (3,668 boys) aged 3–18 years were
recruited and categorized by their body mass index (BMI) into normal weight (N), OW
and O groups regarding their age and sex. AFPs were measured by a non-invasive,
occlusive-oscillometric device. 19.9% (n = 1,356) of the population were OW/O, 911
(516 boys) were OW and 445 (272 boys) were O. After accounting for the effect of
covariates, PWVao did not differ significantly between N (5.9± 0.8 m/s) and OW patients
(5.9 ± 0.8 m/s); and N (6.0 ± 0.7 m/s) and O patients (6.0 ± 0.8 m/s). Aixao was
significantly lower in OW (9.3± 7.4% vs. 7.6± 7.0%, p< 0.00001) and in O patients (9.7
± 8.1% vs. 6.6 ± 7.2%, p < 0.00001) compared to controls. No significant difference
was found regarding SBPao values between controls and OW and O groups (N = 110.7
± 12.4 mmHg vs. OW = 110.3 ± 11.9 mmHg; N = 115.6 ± 14.0 mmHg vs. O =
114.3 ± 12.8 mmHg). According to our results we may conclude that the unchanged
PWVao in O/OW subjects might be due to the compensatory decrease in Aixao, referring
to enhanced vasodilatory status in the studied population.
Keywords: children and adolescents, overweight, obesity, arterial stiffness, pulse wave velocity, augmentation
index, central blood pressure
INTRODUCTION
Prevalence of overweight (OW) and obesity (O) in children and adolescents has increased in
both genders in the past three decades (1). Obesity is associated with significantly decreased life
expectancy (2), most cardiovascular (CV) deaths are attributed to OW and O (3). Obese children
are prone to develop early CV morbidity and are at increased risk for CV mortality during their
adult life (4).
Non-invasive measuring of arterial function parameters (AFPs)—such as aortic pulse wave
velocity (PWVao), aortic augmentation index (Aixao) and aortic systolic blood pressure (SBPao)—
is a widely accepted and recommended in CV risk stratification in adults (5), as these parameters
proved to be strong, independent predictors for CV morbidity and mortality (6–8).
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Numerous works (cc. 400) (9) were published concerning
the relationship between childhood OW/O and arterial stiffness.
Evaluating these publications several studies were using local
stiffness, measuring regional PWV [e.g., carotid (10–12), radial
(13, 14), and tibial (15)]. However, the local and some regional
PWVmeasurements provide information about only the stiffness
at the actual point (carotid) and/or a segment (radial, brachial
tibial) of the measurement. Furthermore, only carotid-femoral
(cfPWV) or PWVao proved to be a powerful marker to predict
the CV morbidity and mortality in adult humans (8, 16).
Therefore, papers where not PWVao or cfPWV were measured,
we considered irrelevant from our aspect. Furthermore, PWVao
rises with age, especially after the beginning of puberty in both
sexes (17, 18). In this age range, the slope of the increase in
the PWVao is noticeable, thus merely 2 months difference in
age among adolescents shows a marked, significant increase
in PWVao (18). Consequently, if we would like to compare
PWVao in OW/O subjects with their N (normal weight) pupils,
the identical age should be crucial. Obesity in children and
adolescents is characterized by chronic sympathetic overdrive.
Sympathetic overactivity occurs in obese patients, as evidence
of increased heart rate, blood pressure and cardiac output (19).
Moreover, AFPs are strongly influenced by the actual brachial
systolic blood pressure (SBPbrach) (20), thus SBPbrach should be
the same in the investigated OW/O patients and controls (normal
weight, N). After a careful review of the available scientific
literature, where the sex ratio of the studied population was
given, the mean age and the SBPbrach of OW/O patients and
control groups was identical, only the most relevant PWVao or
cfPWV measurement was performed, no paper fulfilled these
rigorous criteria.
Therefore, the aim of our study was to compare the PWVao,
Aixao, SBPao, and SBPbrach measured simultaneously in OW/O
patients and healthy subjects in a population of the wide age
range (3–18 years), where the patients and control groups were
accurately matched by age, sex and SBPbrach to eliminate their
effects on AFPs. We intended to apply an easy-to-use, user-
independent occlusive-oscillometric device, which enabled us to




6,816 subjects (3,668 boys) aged 3–18 years were recruited
from elementary, primary, and high schools in Szolnok town
(Hungary) between 2012 and 2016. All the subjects were
Caucasian without any chronic diseases, and they were not on
any regularmedications. Informed consent for themeasurements
was asked for from the parents of the subjects. The protocol
was reviewed and approved by the local Institutional Ethics
Committee of the University of Pécs, Pécs, Hungary.
Methods
Anthropometric measurements (body weight and height) of each
subject were carried out according to theWHO recommendation
(Kern MGB 150K 100 type electronic scale, MSF 200 type
steel strip stadiometer, Kern & SOHN GmbH, Germany) (21).
Subjects were categorized by their body mass index (BMI) into
N (BMI < 90 percentile), OW (90 percentile ≤ BMI < 98
percentile), and O (BMI ≥ 98 percentile) groups regarding their
age and sex as well (22).
A non-invasive, occlusive-oscillometric device (Arteriograph,
TensioMed Ltd, Budapest, Hungary) was used to the
AFPs measurements, for which the operating procedure,
in practice, did not differ from a standard digital blood
pressure measurement. Clinical use of the Arteriograph is
user-independent, painless and takes only 2min with a one-
cuff method, hence it is well tolerated by the youngest age
group as well. Non-invasive and invasive validations and the
detailed method of the device have been published previously
(23, 24). The device showed the best variance and reproducibility
according to comparative studies against applanation tonometry
and piezoelectric methods (23). Furthermore, Arteriograph
formerly was used in a large cohort to determine the PWVao
and Aixao values (percentiles) in a normal, healthy population
aged between 3 and 18 years (18, 25). Since the device is
user-independent, interobserver and intraobserver errors of
the sternal notch-pubic bone distance measurements are only
relevant, which have been published earlier and proved to be
well within acceptable limits (18). Measurements were taken
after a 10-min rest in a comfortable, supine position at room
temperature in kindergartens, elementary, and high schools.
Statistics
Data are reported as mean and SD for continuous data. For
statistical tests “p” value < 0.05 was used for significance.
Bivariate correlation was used for testing correlations between
themeasured parameters and to generate the descriptive statistics
of the original data. Statistical analysis was performed with the
SPSS 23.0.0.0 statistical package (SPSS Inc., Chicago, Illinois,
USA) and R (version 3.4.4) MatchIt (version 3.0.2) package.
Propensity Score Analysis
Our data indicated that the distribution of age and sex
were significantly different in the different weight categories.
Furthermore, strong correlations were observed between the
anthropometric, hemodynamic, and arterial function parameters
(Supplementary Table 1). To account for the effect of covariates
on AFPs propensity score matching was carried out using the
“Nearest Neighbor” method with the grouping variable weight
(BMI category of N, OW, and O) and SBPbrach, age and sex
as variables to match on. The resulting groups contained 911
matched individuals in case of control vs. OW and 445 matched
individuals in case of control vs. O cases that had an almost
identical distribution of SBPbrach, age and sex. The plot of the
mean of each covariate against the estimated propensity score,
separately by weight status is shown in Supplemental Digital
Content (Supplementary Figure 1).
RESULTS
Totally 6,816 subjects (boys n = 3,668; 53.8%) were involved
in this study. Among boys 516 were OW (14.1%), 272 were O
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(7.4%), whereas in girls 395 (12.5%) were OW and 173 (5.5%)
were O. The total prevalence of OW and O was significantly
higher in boys (21.5%) than in girls (18%) in girls (p < 0.001).
Altogether 19.9% (n = 1 356) of the population were OW/O and
80.1% (n= 5 460) of the participants were N.
Baseline characteristics of the investigated cohorts grouped
by age and weight categories are summarized for boys (Table 1)
and girls (Table 2). Bodyweight, height, BMI, SBPbrach, diastolic
blood pressure (DBPbrach), mean arterial pressure (MAP), pulse
pressure (PP) elevated with increasing age in both genders in
every weight category, while heart rate (HR) decreased.
Mean HR and SBPbrach values showed an increment with
increasing BMI categories (Table 3). HR showed a clinically
insignificant increased mean value in OW group than in N
subjects (79.6 ± 14.1/min vs. 79.5 ± 14.9/min, non-significant).
However, the HR was significantly increased in O group
compared to N group (82.5 ± 13.5/min vs. 79.5 ± 14.9/min, p
< 0.0001). The mean HR values were also significantly different
in OW and O groups (79.6 ± 14.1/min vs. 82.5 ± 13.5/min, p <
0.02). Mean SBPbrach was higher in OW, and higher in O patients,
than in N subjects (N = 117.7 ± 13.1 mmHg, OW = 125.6 n
± 14.0 mmHg, O = 131.2 ± 15.2 mmHg), the differences were
significant between every patient groups (p < 0.0001).
Characteristics of the propensity score matched groups and
clarified AFPs are summarized in Table 4.
Mean age was significantly lower in O group (11.8 ± 3.6 ys)
compared to OW group (12.7 ± 3.8 ys) (p < 0.001). Sex ratio
was the same in the investigated groups. The mean body height
was almost the same both in OW and O groups compared to
controls, the difference was 0.8 cm (NS, p = 0.39) and 1.6 cm
(NS, p = 0.28), respectively. Obviously, the mean body weight
was significantly higher in OW and O groups than in controls.
Although the O patients were younger, their mean SBPbrach was
significantly higher (131.2 ± 15.2 mmHg) than was in OW
patients (125.6± 14.0 mmHg) (p < 0.0001).
After the elimination of the alternating effects of age, sex and
SBPbrach, PWVao values were not significantly different between
the propensity score matched N patients (5.9± 0.8 m/s) and OW
patients (5.9 ± 0.8 m/s) and between N patients (6.0 ± 0.7 m/s)
and O patients (6.0± 0.8 m/s). A significant difference was found
between N andOWpatients in Aixao, namely, in N patients Aixao
was 9.3 ± 7.4% whereas it was 7.6 ± 7.0% in OW patients (p
< 0.00001), and Aixao was higher in N subjects (9.7 ± 8.1%)
compared to O patients (6.6± 7.2%), which difference proved to
be statistically significant (p < 0.00001) as well. Regarding SBPao
no significant difference was found between N and OW (110.7±
12.4 mmHg vs. 110.3 ± 11.9 mmHg) subjects. In the same way,
the difference was not significant between the SBPao values of
propensity score matched N and O subjects (115.6± 14.0 mmHg
vs. 114.3± 12.8 mmHg).
DISCUSSION
The most important finding of our study is that no difference was
found regarding PWVao between N and OW, N and O patients
after accounting for the effect of covariates. Furthermore, we
observed a marked, significant decrease of Aixao in OW, and
a markedly more significant decrease in O patients. Finally—
similarly to PWVao–no differences were found regarding SBPao
neither in OW, nor in O patients in a properly matched analysis.
PWVao
With the use of propensity score analysis, no significant
difference was found within the different weight categories
regarding PWVao. This is in apparent disagreement with
previous reports indicated increased PWVao in O children and
adolescents (26, 27). Analyzing the reference values of PWVao
measured in children and adolescents (18), it is apparent that the
median percentile curve of PWVao shows a flat period between
the age of three and the beginning of puberty with a steeper
increase thereafter in both sexes. Therefore, it is necessary to
match the age of the investigated patients and control groups
precisely. Only three publications were found in which the mean
age of the examined groups were identical (26–28). However, in
these studies, SBPbrach differed in the different studied patients’
groups, i.e., the SBPbrach was higher in the OW/O groups
compared to the controls. It is well known that the PWVao
is significantly dependent on the SBPbrach (20), namely the
higher the SBPbrach, the higher the PWVao. Consequently, in
these studies, the elevated PWVao may originate from increased
SBPbrach. Eliminating the possiblemodifying factors, age, sex, and
SBPbrach matched control groups were formed in our study. As
a result of this, no significant differences were found regarding
PWVao. Charakida et al. published data on PWV in children
(over 6,000 subjects) with elevated BMI, however, they measured
regional (radial) PWV, not aortic. Unfortunately, predicting the
value of regional (brachial, radial, tibial) PWV is not established
in cardiovascular morbidity and mortality, so it is considered
irrelevant from our aspect (13). Lurbe et al. (29) published
AFPs data in overweight and obese children, nevertheless, the
difference in age between the investigated groups was more than
1 year, which might lead to misinterpretations in the aspect of
AFPs (obese 12 ± 2.2 y vs. overweight 13 ± 2.1 y vs. non-obese
13.4± 2.6 y).
Aixao
Aixao a measure of central wave reflection, is strongly associated
with peripheral arterial resistance (30), which is determined
mainly by the tone of small arteries and arterioles. From the
cited three studies (26–28) only Mocnik et al. measured Aix, and
they found that the Aix was lower in OW/O patients than in
controls (28). Unfortunately, it was not published whether Aixao
or Aixbrach was measured. Aixao and Aixbrach are correlated very
strongly, they are basically identical, only the scaling is different
between aortic and brachial Aix (24). Thus, Mocnik’s findings
support our observed results where we have found the Aixao
to be significantly lower in OW/O patients groups compared to
N subjects.
Nevertheless, the enhanced wave reflection in small children
is a well-known phenomenon (31), moreover, our working group
proved that the increased Aixao detected in early childhood can
only be caused by the shorter body height (aortic length) (25).
Therefore, it is possible, that the observed differences regarding



























TABLE 1 | Characteristics for boys.
Age n/nsum Weight Height BMI SBPbrach DBPbrach MAP PP HR PWVao Aixao SBPao
(years) (kg) (cm) (%) (mmHg) (mmHg) (mmHg) (mmHg) (1/min) (m/s) (%) (mmHg)
(A) NORMAL WEIGHT n = 2880
3 53/62 15.8 ± 2.3 104.1 ± 6.4 14.6 ± 1.7 103.7 ± 6.7 61.7 ± 7.8 76.5 ± 7.8 45.5 ± 10.3 97.8 ± 16.1 5.4 ± 0.5 19.2 ± 8.5 97.4 ± 8.0
4 74/88 17.7 ± 2.6 109.2 ± 7.3 14.8 ± 1.6 104.7 ± 8.4 61.0 ± 7.2 76.4 ± 8.1 45.7 ± 8.4 92.5 ± 12.8 5.5 ± 0.6 16.1 ± 6.4 96.3 ± 9.0
5 132/153 20.0 ± 2.7 116.0 ± 6.3 14.8 ± 1.5 107.1 ± 7.9 62.8 ± 6.1 78.5 ± 7.6 46.7 ± 9.7 91.5 ± 12.6 5.4 ± 0.6 15.2 ± 5.8 98.6 ± 9.2
6 193/222 22.2 ± 2.9 122.6 ± 5.8 14.7 ± 1.4 107.1 ± 9.6 62.7 ± 6.8 77.8 ± 7.6 45.7 ± 9.0 87.0 ± 12.4 5.4 ± 0.6 13.9 ± 5.9 97.9 ± 10.2
7 147/187 24.6 ± 3.3 127.4 ± 6.2 15.1 ± 1.4 108.6 ± 8.8 63.0 ± 6.7 78.4 ± 7.0 46.6 ± 8.5 82.7 ± 13.0 5.3 ± 0.6 13.3 ± 6.2 98.7 ± 8.9
8 139/180 27.8 ± 4.2 133.5 ± 7.0 15.6 ± 1.5 108.6 ± 8.7 63.0 ± 6.0 78.2 ± 6.2 45.5 ± 6.7 79.6 ± 13.1 5.4 ± 0.6 13.0 ± 6.5 98.2 ± 8.7
9 159/199 31.2 ± 5.3 138.4 ± 7.4 16.2 ± 1.7 110.8 ± 8.6 65.4 ± 6.7 80.3 ± 6.7 45.9 ± 6.2 79.8 ± 13.9 5.4 ± 0.6 11.3 ± 6.0 100.0 ± 8.7
10 122/181 35.2 ± 5.6 144.1 ± 6.7 16.9 ± 1.8 110.6 ± 8.3 64.5 ± 5.4 80.1 ± 5.9 46.5 ± 7.9 76.5 ± 11.8 5.4 ± 0.6 10.4 ± 5.7 99.6 ± 8.0
11 134/195 37.5 ± 6.6 148.1 ± 8.3 17.0 ± 1.9 111.1 ± 8.2 64.8 ± 6.0 80.3 ± 6.4 46.6 ± 5.9 73.9 ± 11.9 5.4 ± 0.6 11.3 ± 6.4 99.9 ± 7.9
12 170/232 43.6 ± 8.6 156.0 ± 9.4 17.8 ± 2.1 115.6 ± 10.3 65.7 ± 6.8 82.5 ± 7.4 49.9 ± 7.8 77.3 ± 14.5 5.6 ± 0.7 8.1 ± 6.3 102.2 ± 8.9
13 245/331 50.0 ± 8.7 163.5 ± 9.5 18.6 ± 1.9 120.2 ± 10.7 66.4 ± 6.7 84.5 ± 7.3 53.9 ± 9.1 76.9 ± 13.8 5.7 ± 0.7 5.8 ± 5.3 104.7 ± 9.0
14 301/410 55.8 ± 9.1 170.4 ± 9.3 19.1 ± 1.9 123.5 ± 11.3 67.6 ± 6.3 86.3 ± 7.2 55.8 ± 8.8 75.4 ± 13.9 6.0 ± 0.7 5.0 ± 5.7 107.2 ± 10.1
15 304/374 59.6 ± 8.5 174.3 ± 7.7 19.6 ± 2.0 125.0 ± 11.8 68.9 ± 7.1 87.7 ± 8.0 56.1 ± 9.2 72.2 ± 13.1 6.0 ± 0.6 4.9 ± 5.4 108.6 ± 10.4
16 288/351 63.0 ± 8.9 176.6 ± 7.3 20.2 ± 2.2 129.0 ± 13.0 70.5 ± 7.3 90.0 ± 8.5 58.5 ± 9.5 73.3 ± 15.0 6.2 ± 0.6 5.2 ± 6.0 111.9 ± 11.0
17 295/356 65.6 ± 8.8 178.3 ± 7.0 20.6 ± 2.2 130.1 ± 12.9 70.3 ± 7.2 90.2 ± 8.1 59.6 ± 10.4 71.4 ± 13.2 6.3 ± 0.7 5.2 ± 5.8 112.5 ± 10.9
18 124/147 68.2 ± 8.2 179.5 ± 6.7 21.1 ± 2.0 131.7 ± 11.5 68.2 ± 7.6 89.4 ± 7.5 63.1 ± 10.5 71.4 ± 13.8 6.4 ± 0.5 5.3 ± 5.1 113.0 ± 9.9
2880/3668
(B) OVERWEIGHT n = 516
3 8/62 18.4 ± 2.1 101.3 ± 6.5 17.9 ± 0.3 105.0 ± 7.4 61.0 ± 5.3 75.9 ± 6.1 44.9 ± 5.8 98.3 ± 10.7 5.4 ± 0.8 14.2 ± 7.0 95.9 ± 7.5
4 12/88 23.1 ± 4.9 111.7 ± 11.5 18.3 ± 0.5 111.0 ± 9.0 64.5 ± 7.1 81.6 ± 10.1 51.3 ± 11.9 89.8 ± 10.9 5.1 ± 0.6 14.5 ± 6.5 104.1 ± 14.5
5 13/153 25.3 ± 3.4 117.4 ± 6.7 18.3 ± 0.7 113.6 ± 8.5 65.8 ± 6.3 82.2 ± 6.7 49.3 ± 8.9 87.9 ± 12.5 5.3 ± 0.6 15.6 ± 7.2 102.7 ± 7.3
6 12/222 29.7 ± 4.0 127.0 ± 8.1 18.3 ± 0.5 112.5 ± 13.6 62.9 ± 6.7 79.4 ± 8.3 49.6 ± 9.8 85.3 ± 10.5 5.2 ± 0.5 11.2 ± 5.1 99.5 ± 10.6
7 26/187 33.0 ± 3.3 131.7 ± 6.4 19.0 ± 0.7 116.5 ± 9.3 68.2 ± 5.1 84.6 ± 6.2 49.1 ± 7.2 87.6 ± 15.5 5.3 ± 0.7 12.1 ± 6.9 105.0 ± 8.7
8 24/180 36.9 ± 4.6 136.3 ± 7.6 19.8 ± 0.9 112.9 ± 7.5 65.9 ± 4.6 81.5 ± 5.2 47.0 ± 5.0 80.2 ± 10.6 5.2 ± 0.6 9.5 ± 5.2 100.6 ± 6.8
9 20/199 41.5 ± 4.3 141.2 ± 6.6 20.8 ± 1.0 117.7 ± 7.8 65.9 ± 4.7 83.2 ± 5.1 51.8 ± 6.6 76.6 ± 9.4 5.4 ± 0.5 11.5 ± 4.7 105.0 ± 7.0
10 29/181 49.4 ± 5.1 148.7 ± 6.5 22.3 ± 1.1 119.0 ± 9.0 68.5 ± 7.4 85.2 ± 6.4 51.3 ± 9.4 82.7 ± 14.0 5.6 ± 0.8 8.3 ± 6.7 105.9 ± 10.1
11 39/195 53.1 ± 7.3 152.7 ± 8.9 22.7 ± 1.4 121.5 ± 10.2 68.5 ± 6.9 86.1 ± 7.4 53.0 ± 7.2 75.6 ± 13.3 5.6 ± 0.8 8.7 ± 6.4 107.4 ± 8.5
12 39/232 60.4 ± 8.0 159.8 ± 8.8 23.6 ± 1.5 122.6 ± 7.9 67.8 ± 6.5 86.4 ± 6.2 55.6 ± 9.3 78.1 ± 13.2 5.7 ± 0.7 5.3 ± 4.3 107.1 ± 7.8
13 48/331 67.6 ± 7.9 166.6 ± 8.1 24.3 ± 1.5 126.5 ± 10.8 66.9 ± 8.8 87.0 ± 9.3 60.3 ± 9.4 75.1 ± 10.3 6.0 ± 0.7 6.6 ± 7.5 110.8 ± 13.1
14 81/410 74.2 ± 8.9 171.3 ± 8.9 25.2 ± 1.3 131.3 ± 12.9 68.9 ± 7.7 89.7 ± 8.2 62.4 ± 11.1 76.0 ± 14.2 6.3 ± 0.7 4.4 ± 6.0 112.6 ± 10.5
15 52/374 77.5 ± 7.7 174.9 ± 7.1 25.3 ± 1.4 134.9 ± 13.5 70.7 ± 6.4 92.1 ± 7.6 64.2 ± 11.7 73.0 ± 11.3 6.1 ± 0.7 5.5 ± 7.7 116.6 ± 12.1
16 46/351 82.5 ± 7.6 178.0 ± 6.9 26.0 ± 1.1 135.0 ± 13.2 71.8 ± 7.9 92.9 ± 9.1 63.5 ± 9.5 70.9 ± 11.6 6.2 ± 0.6 3.9 ± 6.4 116.4 ± 12.7
17 46/356 83.8 ± 8.6 178.3 ± 8.3 26.3 ± 1.1 137.1 ± 13.2 72.2 ± 7.6 94.0 ± 9.5 65.5 ± 10.4 72.5 ± 12.5 6.5 ± 0.6 4.7 ± 6.2 118.3 ± 12.3







































































TABLE 1 | Continued
Age
(years)
n/nsum Weight Height BMI SBPbrach DBPbrach MAP PP HR PWVao Aixao SBPao
(kg) (cm) (%) (mmHg) (mmHg) (mmHg) (mmHg) (1/min) (m/s) (%) (mmHg)
(C) OBESE n = 272
3 1/62 21.0 ± NA 104.0 ± NA 19.4 ± NA 111.0 ± NA 65.0 ± NA 80.0 ± NA 46.0 ± NA 110.0 ± NA 5.1 ± NA 9.7 ± NA 99.0 ± NA
4 2/88 27.5 ± 2.1 117.5 ± 3.5 19.9 ± 0.3 119 ± 21.2 56.5 ± 5.0 77.5 ± 3.5 62.5 ± 26.2 84.5 ± 16.3 4.8 ± 0.1 9.6 ± 1.8 102.4 ± 13.4
5 8/153 34.5 ± 4.3 123.6 ± 4.1 22.6 ± 2.4 128.5 ± 16.0 64.1 ± 8.1 86.6 ± 9.8 68.1 ± 18.2 95.0 ± 16.9 6.0 ± 0.7 10.4 ± 4.5 114.9 ± 15.3
6 17/222 34.8 ± 4.5 124.9 ± 4.5 22.2 ± 1.6 116.9 ± 10.4 62.4 ± 7.1 81.0 ± 7.2 55.7 ± 13.1 85.5 ± 13.0 5.4 ± 0.5 9.6 ± 5.0 103.4 ± 9.4
7 14/187 43.8 ± 5.5 135.8 ± 6.3 23.7 ± 1.9 123.6 ± 12.2 67.0 ± 6.5 85.9 ± 7.2 56.6 ± 11.3 83.6 ± 13.6 5.3 ± 0.6 10.0 ± 6.7 109.4 ± 10.5
8 17/180 49.5 ± 8.4 139.6 ± 8.4 25.3 ± 2.5 120.6 ± 7.8 70.0 ± 4.3 87.0 ± 4.5 50.7 ± 7.7 81.2 ± 11.3 5.5 ± 0.7 9.6 ± 5.3 107.3 ± 5.5
9 20/199 55.2 ± 6.6 145.6 ± 6.4 26.0 ± 1.8 124.5 ± 10.4 69.4 ± 4.3 87.9 ± 5.1 55.1 ± 10.0 86.4 ± 11.7 5.8 ± 0.6 6.7 ± 6.9 109.2 ± 8.3
10 30/181 63.2 ± 9.6 149.7 ± 7.2 28.2 ± 3.6 124.3 ± 10.5 68.3 ± 7.5 87.1 ± 8.2 56.3 ± 7.5 81.7 ± 14.1 5.7 ± 0.7 5.0 ± 4.4 108.8 ± 9.3
11 22/195 70.8 ± 8.6 157.1 ± 7.5 28.6 ± 2.5 130.0 ± 10.8 72.3 ± 7.3 91.6 ± 7.1 57.7 ± 10.6 77.3 ± 12.3 5.9 ± 0.6 5.2 ± 4.5 112.9 ± 8.5
12 23/232 80.3 ± 8.9 162.7 ± 5.6 30.3 ± 3.0 130.0 ± 9.5 67.7 ± 6.6 88.5 ± 6.5 62.2 ± 8.9 81.2 ± 14.6 6.0 ± 0.5 3.3 ± 3.3 110.7 ± 7.7
13 38/331 85.3 ± 11.0 167.0 ± 7.2 30.5 ± 2.6 134.1 ± 14.5 68.3 ± 8.8 90.3 ± 9.4 66.0 ± 12.7 82.8 ± 10.6 6.3 ± 0.8 3.4 ± 8.6 114.5 ± 12.2
14 28/410 91.9 ± 16.0 170.6 ± 9.5 31.4 ± 3.0 132.0 ± 14.5 69.9 ± 9.0 90.6 ± 10.1 62.1 ± 10.0 75.7 ± 8.9 6.4 ± 0.6 4.1 ± 7.8 113.8 ± 12.2
15 18/374 97.7 ± 10.6 173.7 ± 5.9 32.3 ± 3.1 146.3 ± 15.1 76.9 ± 9.4 99.9 ± 10.5 69.4 ± 9.8 72.4 ± 13.7 6.6 ± 0.8 4.0 ± 4.4 125.3 ± 13.1
16 17/351 101.9 ± 10.9 176.3 ± 6.4 32.8 ± 3.2 145.8 ± 15.8 78.1 ± 10.5 101.3 ± 13.1 69.5 ± 10.7 76.3 ± 13.9 6.5 ± 0.9 7.2 ± 5.8 128.2 ± 17.1
17 15/356 104.8 ± 10.5 179.3 ± 6.2 32.6 ± 2.5 146.8 ± 16.1 77.8 ± 7.8 100.9 ± 9.3 69.0 ± 13.6 75.3 ± 16.6 6.7 ± 0.8 4.4 ± 5.9 125.7 ± 12.3
18 2/147 89.0 ± 7.1 171.0 ± 5.7 30.4 ± 0.4 153.0 ± 19.8 84.0 ± 4.2 107.0 ± 9.9 69.0 ± 15.6 72.0 ± 4.2 5.8 ± 0.0 8.1 ± 1.9 134.2 ± 16.6
272/3668
Data are reported as mean ± SD. Aixao, aortic augmentation index; BMI, body mass index; DBPbrach, brachial diastolic blood pressure; HR, heart rate; MAP, mean arterial blood pressure; PP, pulse pressure; PWVao, aortic pulse wave





































































TABLE 2 | Characteristics for girls.
Age
(years)
n/nsum Weight Height BMI SBPbrach DBPbrach MAP PP HR PWVao Aixao SBPao
(kg) (cm) (%) (mmHg) (mmHg) (mmHg) (mmHg) (1/min) (m/s) (%) (mmHg)
(A) NORMAL WEIGHT n = 2580
3 41/49 15.5 ± 2.5 102.0 ± 6.4 14.8 ± 1.2 103.4 ± 8.8 59.8 ± 9.7 74.8 ± 8.0 47.2 ± 13.2 101.8 ± 13.9 5.6 ± 0.7 21.8 ± 8.2 97.7 ± 10.0
4 66/87 17.1 ± 2.5 108.7 ± 6.5 14.5 ± 1.7 106.1 ± 7.7 61.2 ± 6.2 76.9 ± 6.6 46.5 ± 7.9 93.5 ± 11.7 5.4 ± 0.6 18.7 ± 6.2 99.5 ± 9.5
5 82/99 18.5 ± 3.0 114.3 ± 7.3 14.2 ± 1.6 107.7 ± 11.4 62.6 ± 8.0 78.2 ± 9.2 47.0 ± 9.6 94.4 ± 11.1 5.5 ± 0.7 16.3 ± 6.8 99.6 ± 12.5
6 123/148 21.7 ± 3.4 122.4 ± 6.9 14.5 ± 1.5 109.3 ± 11.1 63.5 ± 7.3 79.2 ± 8.7 46.8 ± 8.3 90.1 ± 14.2 5.4 ± 0.7 15.3 ± 6.6 100.1 ± 11.5
7 116/142 23.9 ± 4.9 127.6 ± 7.9 14.6 ± 1.9 110.1 ± 10.8 64.5 ± 7.4 80.2 ± 8.9 46.8 ± 9.0 87.0 ± 13.0 5.5 ± 0.6 14.5 ± 7.3 101.1 ± 12.1
8 94/122 27.4 ± 4.8 133.2 ± 7.4 15.3 ± 1.7 111.1 ± 10.1 64.9 ± 6.2 80.2 ± 7.0 46.1 ± 7.0 85.0 ± 13.5 5.4 ± 0.6 13.1 ± 5.9 100.5 ± 9.2
9 123/157 29.7 ± 5.1 137.6 ± 7.4 15.6 ± 1.7 111.9 ± 10.1 65.2 ± 6.4 80.6 ± 7.1 47.1 ± 8.2 85.2 ± 13.0 5.5 ± 0.7 11.1 ± 5.1 100.5 ± 9.2
10 111/151 34.2 ± 5.8 143.9 ± 7.0 16.4 ± 1.9 113.2 ± 9.9 65.4 ± 5.9 81.4 ± 6.7 47.7 ± 7.0 83.2 ± 12.7 5.6 ± 0.7 10.7 ± 6.3 101.5 ± 8.6
11 104/137 38.2 ± 7.3 149.1 ± 9.4 17.0 ± 2.0 113.7 ± 9.0 66.4 ± 5.9 82.1 ± 6.4 47.4 ± 6.7 81.6 ± 13.7 5.5 ± 0.7 9.7 ± 5.7 101.5 ± 8.1
12 162/218 43.3 ± 7.6 155.7 ± 7.8 17.7 ± 2.0 117.7 ± 12.2 66.9 ± 6.9 83.9 ± 8.1 50.9 ± 8.7 82.4 ± 15.5 5.8 ± 0.6 8.9 ± 6.5 104.1 ± 10.2
13 257/317 49.1 ± 6.7 161.4 ± 6.9 18.8 ± 2.0 119.4 ± 11.7 67.0 ± 6.5 84.5 ± 7.3 52.5 ± 9.5 80.5 ± 14.8 5.9 ± 0.7 7.5 ± 5.6 104.9 ± 10.1
14 301/356 52.0 ± 7.4 164.0 ± 6.6 19.3 ± 2.2 119.9 ± 11.2 68.2 ± 6.5 85.5 ± 7.4 51.7 ± 8.3 78.1 ± 14.4 5.9 ± 0.6 7.4 ± 5.3 105.6 ± 9.7
15 316/374 54.1 ± 7.5 164.8 ± 6.7 19.9 ± 2.2 119.0 ± 10.6 68.8 ± 6.3 85.5 ± 7.3 50.2 ± 7.5 77.4 ± 13.8 5.9 ± 0.6 7.8 ± 5.4 105.3 ± 9.1
16 281/335 54.7 ± 7.2 164.9 ± 6.5 20.1 ± 2.3 120.1 ± 10.5 70.2 ± 6.1 86.9 ± 7.1 50.0 ± 7.7 77.1 ± 13.7 6.1 ± 0.6 8.3 ± 5.6 106.7 ± 9.5
17 271/311 55.4 ± 7.4 166.1 ± 6.4 20.1 ± 2.2 121.2 ± 11.7 69.4 ± 6.7 86.7 ± 7.6 51.8 ± 8.8 76.9 ± 12.1 6.2 ± 0.6 8.6 ± 5.8 107.2 ± 10.2
18 132/145 56.7 ± 6.5 166.0 ± 6.7 20.6 ± 2.0 125.5 ± 13.8 70.9 ± 7.6 89.1 ± 9.1 54.6 ± 9.5 79.6 ± 13.1 6.4 ± 0.5 8.1 ± 5.4 110.6 ± 11.9
2580/3148
(B) OVERWEIGHT n = 395
3 6/49 18.7 ± 3.2 100.5 ± 7.9 18.4 ± 0.6 112.3 ± 6.7 62.3 ± 3.7 79.5 ± 4.3 51.7 ± 11.1 104.7 ± 8.8 5.2 ± 0.6 18.9 ± 7.3 105.0 ± 10.2
4 11/87 20.9 ± 3.6 107.8 ± 8.8 17.9 ± 0.4 109.6 ± 8.2 62.3 ± 6.5 78.2 ± 6.2 47.7 ± 7.6 96.6 ± 17.4 5.2 ± 0.6 14.8 ± 7.2 99.5 ± 5.8
5 11/99 27.4 ± 3.6 122.4 ± 8.5 18.2 ± 0.7 118.2 ± 9.8 69.0 ± 11.9 86.6 ± 12.7 52.6 ± 8.0 94.7 ± 18.5 5.3 ± 0.7 10.9 ± 7.6 107.9 ± 15.4
6 18/148 29.8 ± 4.2 126.4 ± 8.2 18.6 ± 0.8 112.9 ± 12.1 65.1 ± 8.5 81.2 ± 9.3 48.4 ± 7.2 85.2 ± 13.2 5.3 ± 0.5 14.1 ± 8.3 102.3 ± 11.0
7 17/142 32.2 ± 2.6 131.1 ± 4.6 18.7 ± 0.5 114.9 ± 8.7 64.0 ± 5.6 81.1 ± 5.2 50.9 ± 9.2 85.6 ± 8.9 5.2 ± 0.7 10.8 ± 7.8 102.5 ± 9.4
8 15/122 35.9 ± 5.0 134.3 ± 6.7 19.8 ± 1.1 114.9 ± 10.1 66.6 ± 4.8 82.6 ± 5.9 48.3 ± 8.0 79.2 ± 11.9 5.2 ± 0.6 12.4 ± 6.6 103.7 ± 7.6
9 22/157 40.5 ± 5.2 139.3 ± 8.1 20.8 ± 0.8 117.8 ± 10.9 66.0 ± 5.9 83.2 ± 6.9 51.8 ± 8.1 83.5 ± 13.9 5.2 ± 0.8 9.7 ± 7.0 104.4 ± 7.7
10 21/151 47.8 ± 4.5 147.7 ± 6.1 21.9 ± 1.0 121.1 ± 13.6 67.5 ± 8.0 85.7 ± 10.0 54.6 ± 8.5 89.0 ± 16.1 5.5 ± 0.9 5.5 ± 3.7 106.1 ± 12.0
11 22/137 56.1 ± 8.1 155.0 ± 8.9 23.2 ± 1.4 125.2 ± 11.4 66.5 ± 9.6 86.4 ± 10.0 59.7 ± 9.8 86.4 ± 15.4 6.0 ± 0.8 5.2 ± 5.9 108.5 ± 11.8
12 40/218 63.5 ± 7.0 161.0 ± 6.6 24.5 ± 1.7 127.3 ± 11.4 70.5 ± 7.0 89.6 ± 8.1 57.2 ± 8.5 84.4 ± 13.9 5.9 ± 0.7 6.0 ± 4.0 111.4 ± 10.5
13 51/317 64.2 ± 7.6 160.4 ± 9.8 24.9 ± 1.4 127.5 ± 13.4 70.3 ± 7.5 89.4 ± 8.8 57.2 ± 9.6 82.3 ± 13.5 5.9 ± 0.7 7.1 ± 6.2 112.0 ± 11.6
14 43/356 69.0 ± 7.6 163.9 ± 7.2 25.6 ± 1.4 129.0 ± 13.4 71.3 ± 7.6 90.5 ± 8.7 57.7 ± 10.3 79.1 ± 13.4 6.0 ± 0.7 7.4 ± 10.3 113.1 ± 11.8
15 41/374 70.4 ± 6.7 165.0 ± 6.7 25.8 ± 1.3 125.5 ± 11.2 71.6 ± 6.3 89.5 ± 7.2 54.0 ± 9.2 75.3 ± 10.6 6.0 ± 0.7 7.6 ± 4.7 110.7 ± 10.0
16 34/335 73.0 ± 6.7 165.8 ± 6.6 26.5 ± 1.2 131.1 ± 12.6 74.1 ± 7.6 93.0 ± 8.3 57.0 ± 9.8 79.5 ± 13.1 6.1 ± 0.7 6.7 ± 6.4 115.2 ± 11.4
17 33/311 75.5 ± 7.8 166.6 ± 6.9 27.1 ± 1.6 130.9 ± 14.1 72.2 ± 7.6 91.8 ± 9.1 58.8 ± 10.0 74.1 ± 9.6 6.1 ± 0.5 8.2 ± 5.3 115.1 ± 12.3







































































TABLE 2 | Continued
Age
(years)
n/nsum Weight Height BMI SBPbrach DBPbrach MAP PP HR PWVao Aixao SBPao
(kg) (cm) (%) (mmHg) (mmHg) (mmHg) (mmHg) (1/min) (m/s) (%) (mmHg)
(C) OBESE n = 173
3 2/49 21.5 ± 0.7 100.5 ± 0.7 21.3 ± 1.0 127 ± 4.2 73.0 ± 2.8 91.0 ± 2.8 54.0 ± 1.4 97.5 ± 12.0 5.9 ± 0.5 13.1 ± 8.9 114.6 ± 0.3
4 10/87 30.4 ± 4.0 113.6 ± 7.1 23.5 ± 2.4 120.7 ± 7.0 63.5 ± 5.4 82.5 ± 5.2 57.2 ± 6.3 99.0 ± 10.3 5.9 ± 0.7 10.2 ± 10.4 106.3 ± 7.0
5 6/99 29.3 ± 5.3 117.0 ± 8.3 21.3 ± 1.9 113.2 ± 10.1 63.2 ± 4.8 79.7 ± 5.7 50.0 ± 8.6 90.0 ± 11.1 5.4 ± 0.6 16.9 ± 11.5 104.5 ± 14.6
6 7/148 30.6 ± 3.2 118.7 ± 4.2 21.6 ± 1.1 112.1 ± 9.4 63.6 ± 5.6 79.6 ± 6.0 48.6 ± 8.5 89.0 ± 7.4 5.4 ± 0.4 12.0 ± 6.2 100.4 ± 7.5
7 9/142 50.2 ± 11.2 128.9 ± 5.5 30.7 ± 8.7 119.0 ± 10.2 66.3 ± 7.2 83.8 ± 6.5 52.7 ± 10.9 88.0 ± 5.9 5.6 ± 0.6 6.5 ± 5.6 104.2 ± 8.8
8 13/122 49.9 ± 4.3 141.7 ± 3.5 24.9 ± 1.8 122.8 ± 8.9 69.2 ± 5.6 87.2 ± 6.1 53.6 ± 6.7 87.5 ± 6.7 5.5 ± 0.5 7.7 ± 4.8 107.7 ± 7.1
9 12/157 54.1 ± 8.4 144.0 ± 8.7 26.0 ± 2.0 126.5 ± 12.4 70.1 ± 7.6 89.0 ± 8.4 56.4 ± 10.0 84.3 ± 10.8 5.7 ± 0.8 9.7 ± 5.4 112.0 ± 10.6
10 19/151 69.5 ± 10.7 154.7 ± 8.5 29.0 ± 3.3 140.2 ± 14.5 73.4 ± 6.1 95.7 ± 8.1 66.8 ± 11.8 94.2 ± 14.5 6.1 ± 0.8 4.2 ± 9.5 121.2 ± 12.6
11 11/137 69.2 ± 8.7 156.8 ± 8.4 28.1 ± 1.8 125.9 ± 10.4 72.3 ± 9.1 90.3 ± 9.3 53.6 ± 6.0 79.3 ± 15.6 5.8 ± 0.8 9.0 ± 7.5 111.8 ± 12.7
12 16/218 80.6 ± 12.2 160.6 ± 7.1 31.4 ± 5.5 132.1 ± 14.2 70.6 ± 7.7 91.1 ± 8.2 61.4 ± 13.2 81.1 ± 15.4 5.9 ± 0.9 9.2 ± 13.0 116.2 ± 12.1
13 9/317 78.6 ± 11.0 162.2 ± 10.4 29.7 ± 1.3 135.7 ± 6.2 71.3 ± 8.2 92.8 ± 6.8 64.3 ± 7.9 86.1 ± 6.7 6.5 ± 0.5 8.4 ± 10.8 118.9 ± 9.1
14 12/356 84.6 ± 11.4 164.1 ± 6.7 31.3 ± 3.0 140.9 ± 19.3 76.3 ± 11.3 97.8 ± 13.3 64.6 ± 11.4 87.4 ± 9.2 6.6 ± 0.7 4.4 ± 5.4 121.8 ± 16.7
15 17/374 90.6 ± 11.6 166.5 ± 7.1 32.6 ± 2.6 137.4 ± 11.9 74.9 ± 5.7 95.7 ± 7.3 62.4 ± 8.5 79.1 ± 11.5 6.4 ± 0.7 6.5 ± 6.6 119.7 ± 8.9
16 20/335 92.5 ± 11.8 165.9 ± 6.0 33.6 ± 3.7 138.9 ± 10.5 78.3 ± 3.8 98.6 ± 5.5 60.7 ± 8.2 81.6 ± 12.1 6.4 ± 0.5 8.6 ± 6.4 122.5 ± 8.9
17 7/311 94.7 ± 10.5 161.7 ± 9.9 36.2 ± 2.1 147.6 ± 14.7 73.3 ± 8.7 98.0 ± 7.7 74.3 ± 17.0 80.1 ± 14.7 6.2 ± 0.8 5.3 ± 3.6 125.7 ± 10.4
18 3/145 102.0 ± 0.0 169.0 ± 0.0 35.7 ± 0.0 133.7 ± 15.0 62.0 ± 9.5 86 ± 11.1 71.7 ± 5.8 57.7 ± 1.2 5.6 ± 0.4 1.3 ± 4.0 110.8 ± 13.5
173/3148
Data are reported as mean ± SD. Aixao, aortic augmentation index; BMI, body mass index; DBPbrach, brachial diastolic blood pressure; HR, heart rate; MAP, mean arterial blood pressure; PP, pulse pressure; PWVao, aortic pulse wave
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TABLE 3 | Mean heart rate and SBPbrach values in N/OW/O patients.
N OW O N-OW* OW-O* N-O*
Number of patients (n) 5460 911 445
Heart rate 79.5 ± 14.9 79.6 ± 14.1 82.5 ± 13.5 NS p = 0.02 p < 0.0001
(1/min) (p = 0.98)
SBPbrach 117.7 ± 13.1 125.6 ± 14.0 131.2 ± 15.2 p < 0.0001 p < 0.0001 p < 0.0001
(mmHg)
Data are reported as mean ± SD. HR, heart rate; N, normal weight; O, obese; OW, overweight; SBPbrach, brachial systolic blood pressure; *, Kruskal-Wallis test.
TABLE 4 | Characteristics of OW and O patients vs. controls and AFP values after propensity score matching.
OW O
Controls Patients Welch Controls Patients Welch
t-test t-test
Number of patients (n) 911 911 445 445
Age (years) 12.7 ± 4.4 12.7 ± 3.8 NS/* 11.8 ± 4.6 11.8 ± 3.6 NS/*
Sex ratio 520/391 516/395 NS 271/174 272/173 NS
(boys/girls)
Body height (cm) 155.9 ± 22.9 156.7 ± 20.3 NS p = 0.39 155.9 ± 24.6 154.3 ± 18.8 NS p = 0.28
Body weight (kg) 46.4 ± 18.0 60.4 ± 19.8 p < 0.00001 44.7 ± 19.5 71.5 ± 24.0 p < 0.00001
SBPbrach 124.9 ± 15.1 125.6 ± 14.0 NS 130.8 ± 17.2 131.2 ± 15.2 NS
(mmHg)
PWVao 5.9 ± 0.8 5.9 ± 0.8 NS 6.0 ± 0.7 6.0 ± 0.8 NS
(m/s) p = 0.68 p = 0.66
Aixao 9.3 ± 7.2 7.6 ± 7.0 p < 0.00001 10.7 ± 8.0 6.6 ± 7.2 p < 0.00001
(%)
SBPao 110.7 ± 12.4 110.3 ± 11.9 NS 115.6 ± 14.0 114.3 ± 12.8 NS
(mmHg) p = 0.49 p = 0.14
Data are reported as mean ± SD. Aixao, aortic augmentation index; NS, non-significant; O, obese; OW, overweight; PWVao, aortic pulse wave velocity; SBPao, aortic systolic blood
pressure; SBPbrach, brachial systolic blood pressure; *, mean age was significantly different between OW and O group, p < 0.001.
Aixao between N, OW and O groups might stem from the
differences in body height. As the mean body height was not
significantly different between patients and controls—neither in
case of OW, nor in O—we might declare that the observed
differences regarding Aixao are independent of the body height.
Obesity in children and adolescents is characterized by
chronic sympathetic overdrive (19). Sympathetic overactivity
occurs in obese animals, as evidenced by increased blood
pressure, cardiac output, heart rate as well as the activation
of the renin-angiotensin-aldosterone system (32). In our study
the SBPbrach, the HR was increased in OW patients and it
was significantly higher in O subjects than in controls. This
finding could be explained by the previously mentioned chronic
sympathetic overdrive; consequently, the increased metabolism
will cause a remarkable increase in heart rate, stroke volume
and cardiac output. Wilkinson et al. have found an inverse
linear relationship between HR and Aixao (33). Together these
findings could explain the observed lower Aixao in OW/O
patients. Presumably, due to the increased cardiac output and the
concomitantly increasing SBPbrach and SBPao, the lateral tension
toward the aortic wall is also increased, the aorta dilates; thus, the
aortic wall becomes stiffer and, as its consequence, the PWVao
could be higher. To compensate for the effects of increased
cardiac output and SBPao, the vascular regulation system might
lower the vascular resistance by dilating the small arterioles;
therefore, decreased Aixao could be detected. This finding might
be supported by the observations, which revealed increased nitric
oxide (NO) level in relation to fat accumulation (34).
SBPao
In the overviewed and cited literature SBPao has not been
measured or published. In our study, after the elimination of
the effects of sex, age, and SBPbrach, no significant differences
were found regarding SBPao in OW/O patients and controls.
This observation might originate from the accurately matched
SBPbrach (age and sex also) between patient and control groups,
consequently, in this age period, the SBPao is mainly determined
by SBPbrach, without any detectable morphological or functional
deterioration of the aortic wall.
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Study Limitations
Although the use of BMI is well-known and widely accepted
technique to identify overweight and obesity, it might be
misleading in some cases, because it does not distinguish
fat tissue from muscle tissue, therefore individuals with a
considerable muscular system may have increased BMI resulting
in “artificial” obesity. In our study, age- and sex-based BMI
was used to categories patients, still, other techniques such
as skinfold measurements, waist-hip ratio, or bioelectrical
impedance analysis would be necessary for more proper
weight categorization.
To confirm our theory according to which the sympathetic
overdrive in OW/O patients resulting in increased cardiac output
and elevated SBPbrach, stroke volume and cardiac output should
have been measured by echocardiography in these subjects. In
our study, there is a lack of these data, since it was not the aim
of this investigation. Detailed history taking on overweight and
obesity (onset, duration) and medical history about the closest
family members could add relevant information to this study.
Finally, there is a lack of lifestyle data (smoking, caffeine intake,
eating habits, etc) and detailed laboratory tests (fatty-acid profile,
metabolic panel). Future studies of this working group will collect
the above-mentioned data in order to elucidate the underlying
causes of the observed phenomena and hypothesis.
CONCLUSIONS
Our study comprises anthropometric and AFPs data of a huge
cohort of N/OW/O subjects. Interestingly, by comparing OW/O
population data with the properly matched identical subset of
N subjects, we found that OW/O in children and adolescents
was not associated with increased aortic stiffness. Based on
our results, we may conclude that the pathophysiological
consequences in the circulatory system due to childhood OW/O
are partially compensated hemodynamically in these patients,
presumably by the opening of small arterioles, by decreasing
peripheral arteriolar resistance. Therefore, considering our
findings we might speculate that OW/O does not have any
direct adverse effect on the arterial function in the by us
investigated population. However, it must be emphasized, that
in general accumulation of adipose tissue raises the blood
pressure—as we also presented in this study—resulting in
increased cardiovascular risk in the future. Hence, successful
lifestyle intervention programs (focusing on weight reduction,
cessation of a sedentary lifestyle, sleeping, stress elimination,
and relaxation) may lead to the optimization of the CV
risks in the affected subjects. Furthermore, it would be
important to follow these OW/O patients by monitoring AFPs,
to establish the possible period, when the “haemodynamic
compensation/adaptation” of the arterial system might switch
into deterioration, resulting in early arterial disease.
The moment, when the compensatory functions in OW/O
subjects become insufficient is hardly detectable. For this reason,
we aim to design further studies to detect the beginning of this
unfavorable vascular function changes.
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